These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 9935178)
41. [Experimental studies on the characteristics of suicide gene system HSV-tk/GCV and its effect on dendritic cells]. Wang X; Li L; Feng K; Bai L; Pei X Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):628-31. PubMed ID: 11877036 [TBL] [Abstract][Full Text] [Related]
42. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247 [TBL] [Abstract][Full Text] [Related]
43. Co-transduction of herpes simplex virus thymidine kinase gene and human interleukin-2 gene into mouse ovarian cancer cell line, OVHM. Yamaguchi Y; Takashima I; Hihara J; Ohta K; Shimizu K; Minami K; Yoshida K; Toge T Int J Mol Med; 2000 Aug; 6(2):185-90. PubMed ID: 10891564 [TBL] [Abstract][Full Text] [Related]
44. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model. Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166 [TBL] [Abstract][Full Text] [Related]
45. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908 [TBL] [Abstract][Full Text] [Related]
46. Activation of caspase-3 noninvolved in the bystander effect of the herpes simplex virus thymidine kinase gene/ganciclovir (HSV-tk/GCV) system. Zhang Z; Lin J; Chu J; Ma Y; Zeng S; Luo Q J Biomed Opt; 2008; 13(3):031209. PubMed ID: 18601533 [TBL] [Abstract][Full Text] [Related]
47. Inducible expression of herpes simplex virus thymidine kinase increases sensitivity to ganciclovir but does not enhance bystander effect in breast cancer cells. Patil R; Chavez JB; Yee D Breast Cancer Res Treat; 2000 Jul; 62(2):109-15. PubMed ID: 11016748 [TBL] [Abstract][Full Text] [Related]
48. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation. Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376 [TBL] [Abstract][Full Text] [Related]
50. Herpes simplex virus thymidine kinase and granulocyte macrophage colony-stimulating factor combination gene therapy in a murine CT26 cell colon cancer model. Lee KH; Piao H; Son BR; Heo DS; Kim NK; Kim ST Cancer Gene Ther; 2004 Aug; 11(8):570-6. PubMed ID: 15232602 [TBL] [Abstract][Full Text] [Related]
51. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
53. Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine. Toda M; Martuza RL; Rabkin SD Gene Ther; 2001 Feb; 8(4):332-9. PubMed ID: 11313808 [TBL] [Abstract][Full Text] [Related]
54. Synergistic effect of resveratrol and HSV-TK/GCV therapy on murine hepatoma cells. Xiao J; Wang X; Wu Y; Zhao Q; Liu X; Zhang G; Zhao Z; Ning Y; Wang K; Tan Y; Du B Cancer Biol Ther; 2019; 20(2):183-191. PubMed ID: 30257140 [TBL] [Abstract][Full Text] [Related]
55. A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model. Higashi K; Hazama S; Araki A; Yoshimura K; Iizuka N; Yoshino S; Noma T; Oka M Int J Oncol; 2014 Oct; 45(4):1412-20. PubMed ID: 25051201 [TBL] [Abstract][Full Text] [Related]
56. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death. Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113 [TBL] [Abstract][Full Text] [Related]
57. Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication. Xiao J; Zhang G; Li B; Wu Y; Liu X; Tan Y; Du B Oncotarget; 2017 Jan; 8(1):798-807. PubMed ID: 27903977 [TBL] [Abstract][Full Text] [Related]
58. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model. Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258 [TBL] [Abstract][Full Text] [Related]